Lo que usted debe saber sobre su medicamento para la infección latente de tuberculosis (TB) – Isoniazid y Rifapentine
The Latent TB Infection (LTBI) Treatment Fact Sheet Series is designed to complement patient education delivered by healthcare professionals. Each sheet provides patients with a written reminder of their treatment regimen, medication side effects, actions to take if side effects do occur, tips to help remain adherent to the medication, and instructions in the event a dose of medication is missed.
Author:
Oregon Health Authority, Public Health Division
Audiences:
Adolescents/Youth/Teens, Adults, Black or African American persons, At Risk Persons, Parents/Families, Non-U.S.-born persons, General Public, Hispanic or Latino persons, People experiencing homelessness, Minorities, American Indian or Alaska Native persons, Older Adults, Persons with TB
Topic:
Counseling, TB
Country of Origin:
United States
Global resources for the prevention,
management, and elimination of TB.